Skip to main content
MedinCell S.A. logo

MedinCell S.A. — Investor Relations & Filings

Ticker · MEDCL ISIN · FR0004065605 LEI · 969500R79U6PXCL2FF46 PA Manufacturing
Open in API
Filings indexed 522 across all filing types
Latest filing 2019-01-15 Report Publication Anno…
Country FR France
Listing PA MEDCL

About MedinCell S.A.

https://www.medincell.com/en/

MedinCell S.A. is a pharmaceutical company at the commercial stage that specializes in the development of long-acting injectable (LAI) therapies. The company's core is its proprietary BEPO® technology platform, which enables the controlled and sustained release of active pharmaceutical ingredients over periods ranging from days to months after a single injection. This technology forms a fully biodegradable depot in situ, designed to improve treatment efficiency, enhance patient compliance, and increase the global accessibility of medicines. MedinCell develops a portfolio of LAI products across various therapeutic areas, including psychiatry, advancing its pipeline through both internal research and strategic partnerships with other pharmaceutical organizations.

Recent filings

Filing Released Lang Actions
Communicated under the obligation to provide permanent information / Other communications
Report Publication Announcement Classification · 98% confidence The document is titled "Publication of the 2019 financial calendar" and explicitly states that "MedinCell today published its indicative financial calendar for the year 2019." It lists future dates for key events like Annual results, General Meeting, and Half-Year results. This document is an announcement about the schedule of future corporate events and reports, not the reports themselves. According to Rule 2 (The 'MENU VS MEAL' Rule), if a document is short and announces the publication or schedule of reports, it should be classified as a Report Publication Announcement (RPA).
2019-01-15 English
Communiqués au titre de l'obligation d'information permanente / Autres communiqués
Report Publication Announcement Classification · 99% confidence The document is titled "Publication du calendrier financier 2019" (Publication of the 2019 financial calendar) and explicitly states, "MedinCell publie aujourd'hui son calendrier financier indicatif pour l'année 2019." It then lists future dates for key events like annual results, the General Meeting (AGM), and semi-annual results. Since the document's primary purpose is to announce *when* future reports and meetings will occur, rather than being the report itself (like an 10-K or IR) or the AGM material itself, it fits the definition of a Report Publication Announcement (RPA). The document length (2303 chars) is short, supporting the RPA classification over a full report.
2019-01-15 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre d'actions composant le capital social et au nombre total des droits de vote" (Monthly information relating to the number of shares comprising the share capital and the total number of voting rights). It explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) General Regulation. This type of mandatory monthly disclosure in France, detailing the total number of shares and voting rights, is a specific regulatory filing. While it relates to share capital, it is not a general share issue announcement (SHA) or a transaction in own shares (POS), but rather a mandatory periodic disclosure of the voting base. In the provided schema, this specific type of regulatory disclosure about voting rights and share capital count, especially when mandated by a regulator like the AMF, fits best under the general 'Regulatory Filings' (RNS) category, as there is no specific code for 'Monthly Voting Rights Disclosure'. However, given the content focuses entirely on the total number of shares and voting rights, it is a very specific type of capital/share information disclosure. Since the document is a direct regulatory report and not an announcement *about* a report, and it doesn't fit the other specific codes well (like DVA which is for *results* of votes), RNS is the most appropriate fallback for a specific, non-periodic financial report type not explicitly listed. Upon re-evaluation against the definitions, this is a direct regulatory filing concerning the capital structure and voting rights, which is a common type of filing. Since there is no specific code for 'Share Capital/Voting Rights Disclosure', RNS (Regulatory Filings) is the correct fallback.
2019-01-14 French
Information relative au nombre total de droits de vote et d'actions composant le capital
Share Issue/Capital Change Classification · 95% confidence The document is titled "Information mensuelle relative au nombre d'actions composant le capital social et au nombre total des droits de vote" (Monthly information relating to the number of shares comprising the share capital and the total number of voting rights), and it explicitly references Article 223-16 of the AMF (Autorité des Marchés Financiers) General Regulation. This type of mandatory monthly disclosure in France details the total number of shares and voting rights, often used for tracking ownership thresholds. This specific content aligns best with notifications regarding significant share ownership changes or capital structure updates, although it is a routine regulatory filing. Given the options, it is a specific regulatory disclosure about share capital and voting rights. While it relates to share capital (SHA), the primary function here is a mandatory periodic disclosure of voting rights, which is often captured under general regulatory filings or specific shareholding notifications. Since it is a routine monthly report on the total number of shares and voting rights, it is a specific regulatory filing. It is not a Director's Dealing (DIRS), nor a general share issue (SHA), but a mandatory disclosure of the current capital structure for voting purposes. In the context of the provided definitions, this mandatory disclosure of the total number of shares and voting rights is a specific type of regulatory filing. It is closest to Major Shareholding Notification (MRQ) in spirit (tracking capital structure changes) or a general Regulatory Filing (RNS). However, since it is a routine, mandatory disclosure about the total number of shares and voting rights, and not a specific transaction or a major threshold crossing announcement, it fits best as a general Regulatory Filing (RNS) or potentially a Share Issue/Capital Change (SHA) if interpreted broadly. Given the French context and the nature of the disclosure (monthly capital/voting rights statement), RNS is the most appropriate fallback for a specific, non-standard SEC/major report filing. If a more specific French equivalent existed, it would be used, but RNS serves as the general regulatory announcement category.
2018-12-11 French
Franchissement de seuil
Major Shareholding Notification Classification · 98% confidence The document is titled "Déclaration de franchissement de seuil (article L. 233-7 du code de commerce)" which translates to 'Declaration of crossing a threshold (Article L. 233-7 of the Commercial Code)'. This type of filing in France specifically reports when an investor's stake in a listed company crosses certain ownership thresholds (like 5%, 10%, etc.). This directly corresponds to the definition of a Major Shareholding Notification, which tracks changes in significant share ownership levels crossing thresholds. The code for this is MRQ.
2018-12-11 French
Document availability communications / Half yearly financial report
Interim / Quarterly Report Classification · 100% confidence The document is a comprehensive financial report for the first half-year (April - Sept. 2018) of MedinCell. It contains detailed financial statements, including a consolidated cash flow statement and an income statement, along with management's analysis of the results. It is not a mere announcement or certification, as it provides substantive financial data and performance analysis for a period shorter than a full fiscal year, fitting the definition of an Interim/Quarterly Report. H1 2018
2018-12-03 English

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.